Jochen K. Lennerz, et.al., Loss of Par-1a/MARK3/C-TAK1 kinase leads to reduced adiposity, resistance to hepatic steatosis, and defective gluconeogenesis., Molecular and cellular biology, 2010, 30

http://rdf.ncbi.nlm.nih.gov/pubmed/20733003

Jochen K. Lennerz, et.al., Loss of Par-1a/MARK3/C-TAK1 kinase leads to reduced adiposity, resistance to hepatic steatosis, and defective gluconeogenesis., Molecular and cellular biology, 2010, 30

pubmed

allele

http://purl.org/net/cito/citesAsAuthority

• Mark3<tm1Hpw>
  http://metadb.riken.jp/db/mgi_rdf/MGI:3836595

class

http://purl.org/net/cito/citesAsAuthority

• Mark3<tm1Hpw>
  http://metadb.riken.jp/db/mgi_rdf/MGI:3836595

表現型アノテーション

http://purl.org/net/cito/citesAsAuthority

• decreased white adipose tissue amount_Mark2<tm1Hpw>/Mark2<tm1Hpw>
  http://metadb.riken.jp/0001783I129X1SvJC57BL6Mark2tm1HpwMark2tm1HpwMark2tm1Hpw
• decreased body weight_Mark2<tm1Hpw>/Mark2<+>,Mark3<tm1Hpw>/Mark3<tm1Hpw>
  http://metadb.riken.jp/0001262I129X1SvJC57BL6Mark2tm1HpwMark2Mark3tm1HpwMark3tm1HpwMark2Mark3tm1HpwMark2tm1Hpw
• abnormal adipocyte glucose uptake_Mark3<tm1Hpw>/Mark3<tm1Hpw>
  http://metadb.riken.jp/0004185I129X1SvJC57BL6Mark3tm1HpwMark3tm1HpwMark3tm1Hpw
• improved glucose tolerance_Mark3<tm1Hpw>/Mark3<tm1Hpw>
  http://metadb.riken.jp/0005292I129X1SvJC57BL6Mark3tm1HpwMark3tm1HpwMark3tm1Hpw
• decreased body weight_Mark2<tm1Hpw>/Mark2<tm1Hpw>,Mark3<tm1Hpw>/Mark3<+>
  http://metadb.riken.jp/0001262I129X1SvJC57BL6Mark2tm1HpwMark2tm1HpwMark3tm1HpwMark3Mark2tm1HpwMark3tm1HpwMark3
• increased energy expenditure_Mark3<tm1Hpw>/Mark3<tm1Hpw>
  http://metadb.riken.jp/0004889I129X1SvJC57BL6Mark3tm1HpwMark3tm1HpwMark3tm1Hpw
• postnatal lethality_Mark2<tm1Hpw>/Mark2<tm1Hpw>,Mark3<tm1Hpw>/Mark3<+>
  http://metadb.riken.jp/0002082I129X1SvJC57BL6Mark2tm1HpwMark2tm1HpwMark3tm1HpwMark3Mark2tm1HpwMark3tm1HpwMark3
• decreased adiponectin level_Mark2<tm1Hpw>/Mark2<tm1Hpw>
  http://metadb.riken.jp/0004893I129X1SvJC57BL6Mark2tm1HpwMark2tm1HpwMark2tm1Hpw
• decreased body weight_Mark3<tm1Hpw>/Mark3<tm1Hpw>
  http://metadb.riken.jp/0001262I129X1SvJC57BL6Mark3tm1HpwMark3tm1HpwMark3tm1Hpw
• postnatal lethality_Mark2<tm1Hpw>/Mark2<+>,Mark3<tm1Hpw>/Mark3<tm1Hpw>
  http://metadb.riken.jp/0002082I129X1SvJC57BL6Mark2tm1HpwMark2Mark3tm1HpwMark3tm1HpwMark2Mark3tm1HpwMark2tm1Hpw
• decreased susceptibility to diet-induced obesity_Mark3<tm1Hpw>/Mark3<tm1Hpw>
  http://metadb.riken.jp/0005659I129X1SvJC57BL6Mark3tm1HpwMark3tm1HpwMark3tm1Hpw
• decreased susceptibility to weight gain_Mark2<tm1Hpw>/Mark2<tm1Hpw>
  http://metadb.riken.jp/0010182I129X1SvJC57BL6Mark2tm1HpwMark2tm1HpwMark2tm1Hpw
• abnormal liver physiology_Mark3<tm1Hpw>/Mark3<tm1Hpw>
  http://metadb.riken.jp/0000609I129X1SvJC57BL6Mark3tm1HpwMark3tm1HpwMark3tm1Hpw
• decreased susceptibility to hepatic steatosis_Mark3<tm1Hpw>/Mark3<tm1Hpw>
  http://metadb.riken.jp/0002310I129X1SvJC57BL6Mark3tm1HpwMark3tm1HpwMark3tm1Hpw
• decreased circulating insulin level_Mark3<tm1Hpw>/Mark3<tm1Hpw>
  http://metadb.riken.jp/0002727I129X1SvJC57BL6Mark3tm1HpwMark3tm1HpwMark3tm1Hpw
• decreased liver glycogen level_Mark3<tm1Hpw>/Mark3<tm1Hpw>
  http://metadb.riken.jp/0010398I129X1SvJC57BL6Mark3tm1HpwMark3tm1HpwMark3tm1Hpw
• decreased brown adipose tissue amount_Mark2<tm1Hpw>/Mark2<tm1Hpw>
  http://metadb.riken.jp/0001780I129X1SvJC57BL6Mark2tm1HpwMark2tm1HpwMark2tm1Hpw
• decreased total body fat amount_Mark3<tm1Hpw>/Mark3<tm1Hpw>
  http://metadb.riken.jp/0010025I129X1SvJC57BL6Mark3tm1HpwMark3tm1HpwMark3tm1Hpw
• decreased brown adipose tissue amount_Mark3<tm1Hpw>/Mark3<tm1Hpw>
  http://metadb.riken.jp/0001780I129X1SvJC57BL6Mark3tm1HpwMark3tm1HpwMark3tm1Hpw
• abnormal metabolism_Mark3<tm1Hpw>/Mark3<tm1Hpw>
  http://metadb.riken.jp/0005266I129X1SvJC57BL6Mark3tm1HpwMark3tm1HpwMark3tm1Hpw
• postnatal lethality_Mark3<tm1Hpw>/Mark3<tm1Hpw>
  http://metadb.riken.jp/0002082I129X1SvJC57BL6Mark3tm1HpwMark3tm1HpwMark3tm1Hpw
• increased adiponectin level_Mark3<tm1Hpw>/Mark3<tm1Hpw>
  http://metadb.riken.jp/0004892I129X1SvJC57BL6Mark3tm1HpwMark3tm1HpwMark3tm1Hpw
• hypoglycemia_Mark3<tm1Hpw>/Mark3<tm1Hpw>
  http://metadb.riken.jp/0000189I129X1SvJC57BL6Mark3tm1HpwMark3tm1HpwMark3tm1Hpw
• decreased white adipose tissue amount_Mark3<tm1Hpw>/Mark3<tm1Hpw>
  http://metadb.riken.jp/0001783I129X1SvJC57BL6Mark3tm1HpwMark3tm1HpwMark3tm1Hpw
• embryonic lethality, complete penetrance_Mark2<tm1Hpw>/Mark2<tm1Hpw>,Mark3<tm1Hpw>/Mark3<tm1Hpw>
  http://metadb.riken.jp/0011092I129X1SvJC57BL6Mark2tm1HpwMark2tm1HpwMark3tm1HpwMark3tm1HpwMark2tm1HpwMark3tm1Hpw

トランスクリプトームデータ

http://rdf.ncbi.nlm.nih.gov/pubmed/

• CD15237
  http://metadb.riken.jp/db/BrainTx/TranscriptomeData/CD15237
• CD04689
  http://metadb.riken.jp/db/BrainTx/TranscriptomeData/CD04689